What Activities Irritate a Subchorionic Hematoma?

No single randomized trial has tested which everyday activities make a subchorionic hematoma (SCH) grow or bleed more, so most clinical advice draws on what we know about the anatomy of the bleed, how blood thinners worsen it, and observational data on bed rest. The activities most commonly flagged by providers include vigorous exercise, heavy lifting, sexual intercourse, and anything that spikes blood pressure or increases mechanical stress on the uterus. But the story is more nuanced than a simple “avoid everything” list, and some of the strongest evidence actually points to a medication, not an activity, as the biggest aggravating factor.

What a Subchorionic Hematoma Actually Is

A subchorionic hematoma forms when blood collects between the chorion, the outer membrane surrounding the embryo, and the decidua basalis, the lining of the uterus where the placenta attaches.¹ Think of it as a pocket of blood sitting right next to the developing placenta. The chorion has partially separated from the uterine wall, and blood fills the gap. That blood can stay contained and slowly reabsorb, or it can expand if additional bleeding occurs. This is why activities and substances that promote bleeding, raise blood pressure sharply, or physically jostle the uterine wall are the ones clinicians worry about.

Understanding the location matters. Because the hematoma sits at the interface where the placenta is anchoring itself, anything that increases uterine contractions, disrupts clotting, or creates shearing force between the uterine wall and the membranes has the theoretical potential to make the pocket of blood bigger or prevent it from healing.

Physical Exertion and Heavy Lifting

High-impact exercise, heavy weightlifting, and sustained strenuous activity are the first things most OBs tell you to stop when an SCH is found on ultrasound. The reasoning is mechanical: intense physical exertion raises intra-abdominal pressure, increases blood flow to the uterus, and can trigger low-grade uterine contractions. All of those could, in theory, enlarge the separation between the chorion and the uterine wall or restart bleeding that was beginning to clot.

There is no trial that randomly assigned pregnant women with SCH to “exercise” versus “no exercise” groups and measured what happened. The advice is largely extrapolated from first principles and from observational data suggesting rest helps. In one study, women with SCH who adhered to bed rest had a spontaneous abortion rate of about 10%, compared to roughly 23% among those who did not rest, and their rate of delivering at full term was substantially higher.² That is not the same as proving exercise caused harm, but it does suggest that reducing physical demands on the body correlates with better outcomes when an SCH is present.

What counts as “too much” is where guidelines get vague. Most providers draw the line at anything that raises your heart rate significantly, involves jumping or jarring movements, or requires you to bear down hard (think squatting heavy weights, sprinting, or high-intensity interval training). Light walking and gentle daily tasks are usually considered safe, though your provider may have stricter or more lenient advice depending on the size and location of your hematoma.

Sexual Intercourse

Pelvic rest, meaning no vaginal intercourse and often no orgasm, is among the most common restrictions given to women diagnosed with an SCH. The concern has two layers. First, penetrative intercourse involves direct mechanical contact near the cervix, which can transmit force to the lower uterine segment. Second, orgasm triggers uterine contractions, and even mild contractions could theoretically disturb a blood pocket that is trying to clot and reabsorb.

As with exercise, there are no controlled trials testing whether sex worsens SCH outcomes. The recommendation is based on the same logic: reduce anything that causes uterine contractions or physical disruption to the area. If you have been placed on pelvic rest, it typically lasts until a follow-up ultrasound shows the hematoma has resolved or decreased substantially. Some providers distinguish between small hematomas, where they may be less restrictive, and large ones, where they take a firmer stance.

Aspirin, Blood Thinners, and the Biggest Known Aggravator

If there is one factor with strong quantitative evidence tying it to SCH, it is low-dose aspirin. A study comparing women attending a fertility clinic found that SCH appeared in about 40% of those taking low-dose aspirin, compared to roughly 11% of those who were not. The researchers concluded that aspirin was associated with an almost four-fold increase in SCH occurrence, regardless of the type of fertility treatment or underlying diagnosis.³ Heparin, another blood thinner sometimes used in pregnancy, did not appear to have the same effect in that study.

This is a tricky situation for many women, because low-dose aspirin is often prescribed during pregnancy to prevent preeclampsia or to support IVF pregnancies with a history of implantation failure. If you already have an SCH and are taking baby aspirin, your doctor may weigh the risks on both sides before deciding whether to continue. The key takeaway is that aspirin does not just increase the chance of developing an SCH in the first place; by impairing platelet function, it could also slow the clotting process that allows an existing hematoma to resolve. This makes aspirin use arguably more impactful than any physical activity when it comes to SCH aggravation.

Other medications and supplements that thin the blood, including high-dose fish oil, vitamin E in large amounts, and prescription anticoagulants, have not been studied as directly in connection with SCH. But the mechanism is the same: if something makes it harder for blood to clot, it is reasonable to suspect it could slow recovery of a subchorionic bleed. Bring a full list of what you are taking, including over-the-counter supplements, to your next prenatal visit if you have been diagnosed with an SCH.

Straining, Constipation, and Valsalva Maneuvers

This one gets overlooked. Any time you bear down hard, whether from constipation, heavy coughing, or vomiting, you perform what is known as a Valsalva maneuver: you close the airway and push against it, sharply raising pressure inside the abdomen and chest. That transient spike in abdominal pressure pushes on the uterus and its blood supply. For someone with a stable, small hematoma, this is unlikely to be dramatic. For someone with a large, actively bleeding SCH, repeated hard straining is one of those everyday stresses clinicians would rather you avoid.

This is why some providers recommend stool softeners during the first trimester when an SCH is present. Staying hydrated and eating plenty of fiber are low-effort steps that reduce the frequency of straining. If you are experiencing severe nausea and vomiting in early pregnancy (hyperemesis), the forceful retching itself creates abdominal pressure spikes, and managing the vomiting becomes part of managing the hematoma.

Prolonged Standing and Workplace Demands

Long hours on your feet, repetitive bending, and physically demanding work environments are areas of concern that come up often in online forums but rarely in published research. The logic parallels that of exercise: extended upright posture increases blood pooling in the pelvis, and physically demanding work can involve heavy lifting and Valsalva-like exertion. Some providers advise reduced hours or modified duties for women with large or symptomatic hematomas, while others may not impose restrictions if the hematoma is small and asymptomatic.

The lack of formal evidence here is frustrating. What most women end up working with is a general principle: if an activity is making you cramp, spot, or bleed, back off. If you are feeling fine and the hematoma is small, your provider may not restrict your work life at all. Communication with your OB about your specific job demands is more useful than blanket rules from the internet.

The Bed Rest Debate

Bed rest used to be the automatic prescription for almost any bleeding in early pregnancy. In recent years, the obstetric community has moved away from strict bed rest for most pregnancy complications because large reviews found it does not help and can cause its own problems, like blood clots in the legs and deconditioning. SCH may be a partial exception. The observational data showing lower miscarriage rates in women who rested, about 10% versus 23%, is among the more encouraging numbers in the SCH literature.²

The catch is that this was not a randomized trial. Women who adhered to bed rest may have differed from those who did not in ways that influenced the outcome, like having more family support or less physically demanding jobs. Still, the size of the difference was large enough that many providers continue to recommend at least modified activity restriction for symptomatic SCH. “Modified” usually means no exercise beyond gentle walking, no lifting anything heavier than about ten pounds, pelvic rest, and spending extra time lying down, especially if you are actively spotting.

Full bed rest, where you spend nearly all day in bed, is less commonly prescribed now. Most providers reserve it for women with large hematomas, active heavy bleeding, or other risk factors stacked on top of the SCH.

Why Size Changes Everything

Not all subchorionic hematomas carry the same risk, and the size of the bleed is the single most consistent predictor of how things will go. Early research found that when the hematoma volume was under about 60 milliliters, outcomes tended to be favorable, and when the hematoma was small relative to the gestational sac, the prognosis was also better.⁴ A separate study found that unfavorable outcomes were seen in about 71% of cases and tracked closely with the absolute and relative size of the hematoma, the severity of vaginal bleeding, and whether the hematoma grew or shrank on follow-up ultrasound.⁵

More recent data reinforces this pattern. A large study examining SCH size categories found that “large” hematomas were independently associated with a roughly five-fold increased risk of later placental abruption, even after adjusting for preeclampsia.⁶ For small and medium hematomas, the risk of abruption was not significantly elevated. Meanwhile, another study found no significant differences in rates of cesarean section, fetal growth restriction, or neonatal outcomes between women with SCH and those without.⁷

This size distinction is directly relevant to activity restrictions. If your hematoma is small and stable, your provider may be relatively relaxed about your daily activities. If it is large or growing, you are more likely to be placed on strict modified activity or bed rest. Asking about the size relative to your gestational sac at your next ultrasound gives you a concrete way to gauge how cautious you need to be.

What Progesterone Does and Why It Is Prescribed

Many women with an SCH are given supplemental progesterone, either as vaginal suppositories or oral tablets. Progesterone serves two roles here. First, it supports the uterine lining and helps maintain the pregnancy in general. Second, laboratory research shows it can partially block uterine contractions triggered by thrombin, which is a protein released during bleeding. In cell-based experiments, progesterone reduced thrombin-driven contractions and lowered the expression of inflammatory markers in uterine muscle cells.⁸ That matters because when blood from an SCH sits against the uterine wall, it releases thrombin, which can cause cramping and further irritation.

On the clinical side, one study treated 100 women who had bleeding with ultrasound-confirmed SCH using oral dydrogesterone, a specific type of synthetic progesterone. The miscarriage rate was 7%, compared to roughly 19% in a prior group treated with a different progesterone formulation, a reduction the authors attributed to dydrogesterone’s stronger immunomodulatory effects.⁹ This was not a head-to-head randomized trial, so the comparison should be taken with some caution, but it is consistent with the idea that progesterone support helps calm the uterine environment while the hematoma resolves.

Progesterone is not a direct treatment for the hematoma itself. It does not dissolve the blood clot or shrink the pocket. What it does is reduce the secondary damage: the contractions, the inflammation, and the hormonal dip that can accompany a threatened miscarriage. Think of it as damage control for the environment around the hematoma while your body works on reabsorbing it.

The IVF Connection

If you conceived through in vitro fertilization, your baseline risk of developing an SCH is higher than in a spontaneously conceived pregnancy. One study found SCH in about 22% of IVF pregnancies versus 11% of non-IVF pregnancies.¹⁰ A larger retrospective cohort put the number even higher for fresh embryo transfers, at roughly 28%, with frozen transfers around 23%.¹¹

The reasons are likely multifactorial. The embryo transfer procedure itself involves passing a catheter through the cervix, which can cause minor trauma. Hormonal stimulation creates a uterine lining that may respond differently to implantation. And many IVF patients are on low-dose aspirin, which, as discussed earlier, is the single strongest medication-related risk factor for SCH. If you are in the post-transfer window and you see bleeding, an SCH should be on the radar as a probable explanation, and your fertility clinic will likely already be monitoring for it.

This higher baseline risk also means IVF patients may benefit the most from proactive activity modification. If your clinic has not already discussed activity restrictions after a positive transfer, and especially after SCH is spotted on an early ultrasound, it is worth bringing up. Some fertility clinics are more conservative than general OB practices when it comes to recommending reduced activity in the first trimester.

Preterm Birth Risk and Why Follow-Up Matters

Even after the immediate scare of first-trimester bleeding passes and the hematoma appears to resolve, there is evidence that SCH leaves a footprint on the rest of the pregnancy. A study of over 1,800 women found that preterm birth was more common in those who had a first-trimester SCH, at about 13% compared to 7% in those without one. That association held even after accounting for cervical length, a well-known predictor of preterm delivery.¹²

This does not mean you need to spend the entire pregnancy on edge. But it does mean that the monitoring should not stop once the hematoma disappears from the ultrasound screen. Cervical length checks in the second trimester, awareness of preterm labor signs, and continued communication with your provider about any new symptoms are all reasonable follow-up steps. Some providers will also schedule additional growth scans in the third trimester if the initial SCH was large, given the association between large hematomas and later placental abruption.

Reading Your Own Symptoms

One of the most stressful parts of living with an SCH is not knowing whether what you are experiencing is normal for the condition or a sign that something has gotten worse. A few guidelines can help you sort signals from noise.

Brown spotting: Old blood working its way out. This is usually the hematoma draining and is generally considered a reassuring sign that the blood pocket is shrinking rather than growing.
Bright red bleeding: Fresh blood, which may indicate active bleeding at the separation site. Light spotting can be normal, but if it fills a pad in an hour or comes with cramping, contact your provider.
Cramping without bleeding: Mild cramping is common with SCH because thrombin from the blood irritates the uterine muscle. Severe or rhythmic cramping warrants a call.
Increased bleeding after activity: If you notice that a specific activity, whether exercise, a long day on your feet, or intercourse, consistently triggers spotting or cramping, that is your body telling you the activity is irritating the hematoma. Take it seriously even if your provider’s general advice was permissive.

The pattern of bleeding over time is more informative than any single episode. A hematoma that is shrinking on serial ultrasounds and producing less bleeding is on the right track, regardless of occasional spotting. One that is growing or causing heavier bleeding over days to weeks is the scenario that may require escalated restrictions or closer monitoring. Keeping a simple log of when you bleed, how much, and what you were doing beforehand gives your provider genuinely useful data at your next appointment.